295 related articles for article (PubMed ID: 19528501)
1. Breast tumor cells transendothelial migration induces endothelial cell anoikis through extracellular matrix degradation.
Peyri N; Berard M; Fauvel-Lafeve F; Trochon V; Arbeille B; Lu H; Legrand C; Crepin M
Anticancer Res; 2009 Jun; 29(6):2347-55. PubMed ID: 19528501
[TBL] [Abstract][Full Text] [Related]
2. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
3. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells.
Earley S; Plopper GE
Biochem Biophys Res Commun; 2008 Feb; 366(2):476-82. PubMed ID: 18073135
[TBL] [Abstract][Full Text] [Related]
7. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts.
Saad S; Gottlieb DJ; Bradstock KF; Overall CM; Bendall LJ
Cancer Res; 2002 Jan; 62(1):283-9. PubMed ID: 11782389
[TBL] [Abstract][Full Text] [Related]
8. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion.
Wolf K; Wu YI; Liu Y; Geiger J; Tam E; Overall C; Stack MS; Friedl P
Nat Cell Biol; 2007 Aug; 9(8):893-904. PubMed ID: 17618273
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
10. Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis.
Hu L; Roth JM; Brooks P; Luty J; Karpatkin S
Cancer Res; 2008 Jun; 68(12):4666-73. PubMed ID: 18559512
[TBL] [Abstract][Full Text] [Related]
11. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells.
Pan B; Zhao MH; Chen Z; Lu L; Wang Y; Shi DW; Han PZ
Endocr Relat Cancer; 2007 Dec; 14(4):1063-71. PubMed ID: 18045957
[TBL] [Abstract][Full Text] [Related]
13. Temporal relationship between MMP production and angiogenic process in HUVECs.
Kiran MS; Sameer Kumar VB; Viji RI; Sudhakaran PR
Cell Biol Int; 2006 Sep; 30(9):704-13. PubMed ID: 16829143
[TBL] [Abstract][Full Text] [Related]
14. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
Nishida Y; Miyamori H; Thompson EW; Takino T; Endo Y; Sato H
Cancer Res; 2008 Nov; 68(21):9096-104. PubMed ID: 18974156
[TBL] [Abstract][Full Text] [Related]
15. [Effects of MT1-MMP on the in vitro invasiveness of breast cancer cells].
Yao GY; Zeng MS; Lin P; Song LB; Zhang X; He JH; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):650-3. PubMed ID: 17274367
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.
Shen Q; Lee ES; Pitts RL; Wu MH; Yuan SY
Mol Cancer Res; 2010 Jul; 8(7):939-51. PubMed ID: 20571065
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.
Gu Y; Lee HM; Golub LM; Sorsa T; Konttinen YT; Simon SR
Ann Med; 2005; 37(6):450-60. PubMed ID: 16203617
[TBL] [Abstract][Full Text] [Related]
18. Modulation of membrane type 1 matrix metalloproteinase by LPS and gamma interferon bound to extracellular matrix in intestinal crypt cells.
Alvarado J; del Castillo JR; Thomas LE
Cytokine; 2008 Feb; 41(2):155-61. PubMed ID: 18165051
[TBL] [Abstract][Full Text] [Related]
19. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells.
Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970
[TBL] [Abstract][Full Text] [Related]
20. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7.
Steffen A; Le Dez G; Poincloux R; Recchi C; Nassoy P; Rottner K; Galli T; Chavrier P
Curr Biol; 2008 Jun; 18(12):926-31. PubMed ID: 18571410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
